Syneos Health Stock EBITDA
Syneos Health fundamentals help investors to digest information that contributes to Syneos Health's financial success or failures. It also enables traders to predict the movement of Syneos Stock. The fundamental analysis module provides a way to measure Syneos Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syneos Health stock.
Syneos |
Syneos Health Company EBITDA Analysis
Syneos Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Syneos Health EBITDA | 699.99 M |
Most of Syneos Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Syneos Health reported earnings before interest,tax, depreciation and amortization of 699.99 M. This is 20.22% lower than that of the Life Sciences Tools & Services sector and 101.78% higher than that of the Health Care industry. The ebitda for all United States stocks is 82.04% higher than that of the company.
Syneos EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syneos Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics of similar companies.Syneos Health is currently under evaluation in ebitda category among its peers.
Syneos Fundamentals
| Return On Equity | 0.0209 | |||
| Return On Asset | 0.0263 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.23 B | |||
| Shares Outstanding | 103.72 M | |||
| Shares Owned By Insiders | 0.48 % | |||
| Shares Owned By Institutions | 94.74 % | |||
| Number Of Shares Shorted | 6.76 M | |||
| Price To Earning | 18.05 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 5.39 B | |||
| Gross Profit | 1.25 B | |||
| EBITDA | 699.99 M | |||
| Net Income | 266.5 M | |||
| Cash And Equivalents | 124.2 M | |||
| Cash Per Share | 1.21 X | |||
| Total Debt | 2.9 B | |||
| Debt To Equity | 0.93 % | |||
| Current Ratio | 1.10 X | |||
| Book Value Per Share | 33.69 X | |||
| Cash Flow From Operations | 426.98 M | |||
| Short Ratio | 5.59 X | |||
| Earnings Per Share | 0.70 X | |||
| Price To Earnings To Growth | 1.28 X | |||
| Target Price | 42.5 | |||
| Number Of Employees | 28.77 K | |||
| Beta | 1.58 | |||
| Market Capitalization | 4.43 B | |||
| Total Asset | 8.2 B | |||
| Retained Earnings | 167.69 M | |||
| Working Capital | 219.25 M | |||
| Current Asset | 1.09 B | |||
| Current Liabilities | 1.07 B | |||
| Z Score | 1.92 | |||
| Net Asset | 8.2 B |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |